Philippines Department of Health Greenlights Ivermectin Off Label for COVID-19

Philippines Department of Health Greenlights Ivermectin Off Label for COVID-19

The Philippines has taken a step closer to fully authorizing ivermectin for the use against SARS-CoV-2, the virus behind COVID-19.The Department of Health went on the record that the anti-parasitic drug can be used in “off-label” prescription targeting the coronavirus. Up until now, access to the drug for COVID-19 required compassionate use permits; to date, six hospitals secured such a status to access the drug for COVID-19 patients. Much like is the case in America, a licensed physician may prescribe ivermectin off label at his/her own discretion in consultation with the patient. In the Philippines, the doctor will be liable for any associated adverse effects, reported Health Undersecretary Maria Rosario Vergeire in a recent briefing. This is a change in direction from just several days ago, when the government was resisting authorization, as reported by TrialSite. 

The pressure for allowing off-label ivermectin use for the COVID-19 indication has grown from a combination of lawmakers, select physician groups, and patient rights advocates. And as TrialSite reported, the Philippines Food and Drug Administration (FDA) awarded Lloyd Laboratories with a certificate of product reg...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee